NCT06796894 Symptoms, Respiratory Dysfunction and Frailty Level in Allergic and Eosonophilic Asthmatics
| NCT ID | NCT06796894 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hacettepe University |
| Condition | Asthma |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-08-01 |
| Primary Completion | 2026-10-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-08-01 with a primary completion date of 2026-10-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine the level of respiratory dysfunction, symptoms and frailty in patients with asthma according to different endophenotypes (allergic and eosonophilic asthma). In the light of the data obtained, it is thought that rehabilitation approaches that can be determined according to different endophenotypes in line with the evaluated parameters will guide health professionals working in this field. Hypotheses H0: There is no difference between allergic and eosonophilic asthmatics in terms of pulmonary function, respiratory dysfunction, symptoms, dyspnoea, fatigue, rhinitis, perception of breathlessness in activities of daily living, asthma control, level of frailty or quality of life. H1: There is a difference between individuals with allergic and eosonophilic asthma in terms of pulmonary function, respiratory dysfunction, symptoms, dyspnoea, fatigue, rhinitis, perception of breathlessness in activities of daily living, asthma control, level of frailty or quality of life.
Eligibility Criteria
Inclusion Criteria: * Age between 35-75 years, * Diagnosed with allergic or eosonophilic asthma according to the Global Strategy for the Prevention and Treatment of Asthma (GINA). Exclusion Criteria: * Known cognitive impairment, * Having had an acute asthma attack in the last 6 weeks, * Having changed medication in the last 4 weeks.
Contact & Investigator
Ebru Calik Kutukcu
PRINCIPAL INVESTIGATOR
Hacettepe University
Frequently Asked Questions
Who can join the NCT06796894 clinical trial?
This trial is open to participants of all sexes, aged 35 Years or older, up to 75 Years, studying Asthma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06796894 currently recruiting?
Yes, NCT06796894 is actively recruiting participants. Contact the research team at ebru.calik@hacettepe.edu.tr for enrollment information.
Where is the NCT06796894 trial being conducted?
This trial is being conducted at Ankara, Turkey (Türkiye).
Who is sponsoring the NCT06796894 clinical trial?
NCT06796894 is sponsored by Hacettepe University. The principal investigator is Ebru Calik Kutukcu at Hacettepe University. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.